NEI
CRL icon

Northwest & Ethical Investments’s Charles River Laboratories CRL Stock Holding History

Northwest & Ethical Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357K Sell
1,581
-2,577
-62% -$459K 0.01% 359
2026
Q1 		$699K Buy
4,158
+290
+7% +$53.8K 0.02% 356
2025
Q4 		$781K Sell
3,868
-422
-10% -$76.5K 0.02% 337
2025
Q3 		$631K Buy
+4,290
New +$681K 0.01% 381
2016
Q4 		– Sell
-18,400
Closed -$1.53M – 385
2016
Q3 		$1.53M Buy
+18,400
New +$1.54M 0.11% 202

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Northwest & Ethical Investments's CRL Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its Charles River Laboratories (CRL) stake by 62% in Q2 2026, selling an estimated $459K and leaving 1,581 shares worth $357K. The position accounts for 0.01% of the portfolio, ranked #359.

Northwest & Ethical Investments first reported a position in CRL in Q3 2016 and has held it in 5 quarters since. The position peaked at $1.53M in Q3 2016. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Northwest & Ethical Investments held 1,581 shares of Charles River Laboratories worth $357K as of Q2 2026.
  • Northwest & Ethical Investments sold 2,577 Charles River Laboratories shares in Q2 2026, an estimated $459K.
  • Charles River Laboratories made up 0.01% of Northwest & Ethical Investments's portfolio in Q2 2026, its #359 holding.
  • Northwest & Ethical Investments first reported a position in Charles River Laboratories in Q3 2016 and has held it in 5 quarters since.
  • Northwest & Ethical Investments's Charles River Laboratories position peaked at $1.53M in Q3 2016.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.